Haleon (HLN) Stock Forecast & Price Target

GBX 355.20 +2.20 (+0.62%)

As of 11:57 AM Eastern

Haleon - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 3 Analyst Ratings

Sell
1

Hold
1

Buy
1

Based on 3 Wall Street analysts who have issued ratings for Haleon in the last 12 months, the stock has a consensus rating of "Hold." Out of the 3 analysts, 1 has given a sell rating, 1 has given a hold rating, and 1 has given a buy rating for HLN.

Consensus Price Target

GBX 413.50

According to the 3 analysts' twelve-month price targets for Haleon, the average price target is GBX 413.50. The highest price target for HLN is GBX 457, while the lowest price target for HLN is GBX 370. The average price target represents a forecasted upside of 16.41% from the current price of GBX 355.20.

Get the Latest News and Ratings for HLN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Haleon and its competitors.

HLN Analyst Ratings Over Time

Type	Current Forecast 8/8/24 to 8/8/25	1 Month Ago 7/9/24 to 7/9/25	3 Months Ago 5/10/24 to 5/10/25	1 Year Ago 8/9/23 to 8/8/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)	3 Buy rating(s)
Hold	1 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	GBX 413.50	GBX 457	GBX 457	GBX 371.17
Consensus Rating	Hold	Buy	Buy	Moderate Buy

HLN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

HLN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Haleon Stock vs. The Competition

Type	Haleon	Medical Companies
Consensus Rating Score	2.00	2.81
Consensus Rating	Hold	Moderate Buy
News Sentiment Rating	Neutral News See Recent HLN News	Neutral News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
8/1/2025	JPMorgan Chase & Co. 3 of 5 stars	Reiterated Rating	Underweight
7/31/2025	Royal Bank Of Canada 3 of 5 stars	Reiterated Rating	Sector perform	GBX 370	+1.12%
2/28/2025	Berenberg Bank 2 of 5 stars	Boost Target	Buy	GBX 456 ➝ GBX 457	+11.87%
4/18/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy
4/9/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight	GBX 390 ➝ GBX 383	+19.28%
10/11/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target		GBX 340 ➝ GBX 360	+6.82%
8/9/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target		GBX 390 ➝ GBX 387	+18.99%
8/9/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target		GBX 375 ➝ GBX 370	+13.76%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 02:25 PM ET.

Should I Buy Haleon Stock? HLN Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, August 6, 2025. Please send any questions or comments about these Haleon pros and cons to contact@marketbeat.com.

Haleon
Bull Case

Here are some ways that investors could benefit from investing in Haleon plc:

The current stock price is around $4.65, which may present a buying opportunity for investors looking for value.
Haleon plc reported a solid earnings per share of $0.12 for the latest quarter, indicating profitability and potential for future growth.
The company has a return on equity of 6.54%, suggesting effective management and the ability to generate profits from shareholders' equity.
With a market capitalization of approximately £31.57 billion, Haleon plc is positioned as a significant player in the consumer health sector, which can attract institutional investors.
Insider buying activity, with key executives purchasing shares, can signal confidence in the company's future performance and stability.

Haleon
Bear Case

Investors should be bearish about investing in Haleon plc for these reasons:

The stock has experienced fluctuations, with a recent trading volume lower than its average, indicating potential volatility.
Haleon plc has a debt-to-equity ratio of 53.36, which may raise concerns about the company's financial leverage and risk exposure.
Analysts have issued mixed ratings, with some firms maintaining an "underweight" rating, suggesting caution among market experts.
The company's current ratio of 0.84 indicates that it may struggle to meet short-term liabilities, which could affect liquidity.
Despite a positive earnings report, the overall market sentiment may be cautious, impacting stock performance in the near term.

HLN Forecast - Frequently Asked Questions

: According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Haleon is GBX 413.50, with a high forecast of GBX 457 and a low forecast of GBX 370.
: 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last twelve months. There is currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" HLN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLN, but not buy additional shares or sell existing shares.
: According to analysts, Haleon's stock has a predicted upside of 16.41% based on their 12-month stock forecasts.
: Haleon has been rated by research analysts at JPMorgan Chase & Co., and Royal Bank Of Canada in the past 90 days.
: Analysts like Haleon less than other "medical" companies. The consensus rating for Haleon is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how HLN compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (LON:HLN) was last updated on 8/8/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Haleon (HLN) Stock Forecast & Price Target